Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of Exposure Science & Environmental Epidemiology|June 26, 2021
Estimated number of cancers attributable to occupational exposures in France in 2017: an update using a new method for improved estimatesClaire Marant Micallef, Hadrien Charvat, Marie-Tülin Houot, et al.Cancer Causes & Control : CCC|February 22, 2018
The impact of historical breastfeeding practices on the incidence of cancer in France in 2015Kevin D Shield, Laure Dossus, Agnès Fournier, et al.Radiation and Environmental Biophysics|May 9, 2018
Quantitative health impact of indoor radon in FranceRoula Ajrouche, Candice Roudier, Enora Cléro, et al.Current Epidemiology Reports|August 23, 2016
Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy ProjectionKevin D Shield, D Maxwell Parkin, David C Whiteman, et al.International Journal of Cancer|December 12, 2018
The risk of cancer attributable to diagnostic medical radiation: Estimation for France in 2015Claire Marant-Micallef, Kevin D Shield, Jérôme Vignat, et al.Journal of Epidemiology and Population Health|March 20, 2025
Fardeau épidémiologique des virus respiratoires chez les immunodéprimés en FranceClélia Bignon-Favary, Slim Fourati, Nicolas Capit, et al.The British Journal of Nutrition|November 8, 2018
New cancer cases attributable to diet among adults aged 30-84 years in France in 2015Kevin D Shield, Heinz Freisling, Marie-Christine Boutron-Ruault, et al.Occupational and Environmental Medicine|May 9, 2018
Occupational exposures and cancer: a review of agents and relative risk estimatesClaire Marant Micallef, Kevin David Shield, Isabelle Baldi, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 28, 2022
Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in FranceManon Belhassen, Olivier Hanon, Philippe Gabriel Steg, et al.Journal of Comparative Effectiveness Research|March 23, 2026
Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD studyBenoit Polack, Virginie Nerich, Claire Marant Micallef, et al.Pageof 3